Impact of adjuvant immunotherapy on survival of patients with resected stage III melanoma diagnosed in 2003-2011 in the US

被引：0
|
作者：
Jang, S. [1 ]
Wang, H. [2 ]
Venna, S. [1 ]
机构：
[1] Inova Schar Canc Inst, Fairfax, VA USA
[2] Georgetown Univ, Washington, DC USA
来源：
MELANOMA RESEARCH | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FC2-2
引用
收藏
页码：E8 / E9
页数：2
相关论文
共 50 条
  • [1] Impact of Adjuvant Immunotherapy on Overall Survival in a Contemporary Cohort of Patients with Stage III Melanoma
    Cimarron E. Sharon
    Gabriella N. Tortorello
    Kevin Ma
    Andrew J. Sinnamon
    Tara C. Mitchell
    Giorgos C. Karakousis
    John T. Miura
    [J]. Annals of Surgical Oncology, 2023, 30 : 5329 - 5332
  • [2] Impact of Adjuvant Immunotherapy on Overall Survival in a Contemporary Cohort of Patients with Stage III Melanoma
    Sharon, Cimarron E. E.
    Tortorello, Gabriella N. N.
    Ma, Kevin
    Sinnamon, Andrew J. J.
    Mitchell, Tara C. C.
    Karakousis, Giorgos C. C.
    Miura, John T. T.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (09) : 5329 - 5332
  • [3] Management of resected stage III/IV melanoma with adjuvant immunotherapy.
    Johnson, Rebecca
    Atkinson, Victoria
    Bhave, Prachi
    Weppler, Alison Margaret
    Peters, Geoffrey David
    Abed, Afaf
    Lyle, Megan
    Khattak, Muhammad Adnan
    Haydon, Andrew Mark
    Carlino, Matteo S.
    Sandhu, Shahneen Kaur
    Long, Georgina V.
    Menzies, Alexander M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Impact of adjuvant immunotherapy in resected stage II/III/IV melanoma: A single center experience
    Sevillano Tripero, Alberto Rafael
    Ortiz, Carolina
    Lostes, Julia
    Bodet, Domingo
    Ferrandiz, Carla
    Bassas, Patricia
    Chiquillo, Paula
    Villacampa, Guillermo
    Vega-Cano, Kreina Sharela
    Garcia-Patos, Vicente
    Recio, Juan
    Munoz-Couselo, Eva
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Preferences for adjuvant immunotherapy in patients with resected stage III melanoma: A discrete choice experiment.
    Livingstone, Ann
    Menzies, Alexander M.
    Howard, Kirsten
    Stockler, Martin R.
    Morton, Rachael L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Adjuvant Pembrolizumab in Resected Stage III Melanoma
    Barker, Christopher A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (06): : 593 - 593
  • [7] Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma—A Discrete Choice Experiment
    Ann Livingstone
    Kirsten Howard
    Alexander M. Menzies
    Georgina V. Long
    Martin R. Stockler
    Rachael L. Morton
    [J]. The Patient - Patient-Centered Outcomes Research, 2023, 16 : 497 - 513
  • [8] Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma
    Ridolfi, L
    Ridolfi, R
    Riccobon, A
    De Paola, F
    Petrini, M
    Stefanelli, M
    Flamini, E
    Ravaioli, A
    Verdecchia, GM
    Trevisan, G
    Amadori, D
    [J]. JOURNAL OF IMMUNOTHERAPY, 2003, 26 (02): : 156 - 162
  • [9] Trends and variations in the use of adjuvant immunotherapy for stage III melanoma in the US population
    Nasabzadeh, Teresa J.
    Tsai, Huei-Ting
    Tefera, Eshetu
    Venna, Suraj S.
    Potosky, Arnold L.
    Atkins, Michael B.
    Jang, Sekwon
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma-A Discrete Choice Experiment
    Livingstone, Ann
    Howard, Kirsten
    Menzies, Alexander M.
    Long, Georgina V.
    Stockler, Martin R.
    Morton, Rachael L.
    [J]. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2023, 16 (05): : 497 - 513
12345